Open Biosystems, based in Huntsville, is a leading provider of gene editing and gene modulation solutions for academic institutes, pharmaceutical companies, and clinical laboratories. With over a decade of expertise in engineering cell lines, they offer innovative tools to identify genetic drivers of disease and develop precision medicine therapies.
Horizon Discovery, headquartered in Cambridge, UK, with offices in the USA and Japan, specializes in modulating gene function in human and mammalian cell lines. Their services enable the development and validation of diagnostic workflows, as well as the delivery of new therapies for a wide range of applications in the field of precision medicine.
Generated from their website's infomation